You are here - Our region - Infrastructures
CSEM and Creapole/i-net with the support of Inartis Network and in cooperation with swissnex Singapore join forces to organize a one-day Swiss Singapore workshop on microfluidics. Date : Wednesday 22 May 2013, 9:00 — 17:30 Location: Congress Center Basel
Ce premier event d’envergure dédié à la santé numérique permettra à tout un chacun de se faire une idée précise de l’environnement et des enjeux de ce domaine prometteur. Un focus spécial sera mis sur le patient et le diagnostic numérique.
Summary of activity DFB BioScience's primary focus is in the field of Cell Biology and Cell based therapies. The company develops Cell based therapies for treating chronic and acute wounds. Our R&D program includes several products at different development stage (preclinical, clinical, market approval). DFB BioScience can also provide manufacturing services for cell banking and Cell based products clinical manufacturing. The company DFB BioScience is one of DFB Pharmaceuticals’ International branches. DFB Pharmaceuticals Inc., the mother company, is a fully integrated pharmaceutical group composed of two main divisions, DPT Laboratories, a Contract Manufacturing Organization providing customers with drug development and manufacturing services, and Healthpoint, which develops & markets pharmaceutical and medical products for chronic wounds.
CSEM's mission is to operate a center for advanced research and promote industrial development and the collaboration with universities in microtechnology and nanotechnologies.